Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 20, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - October 20, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 28     Next >>     Go To Page:

10/20/18 - Sen. Cassidy Joins National Academy of Medicine's Discussion on Affordable Drugs
Bill Cassidy, R- Louisiana, issued the following news release:. U.S. Senator Bill Cassidy, M.D., a member of the Senate health committee, recently joined National Academy of Medicine President Victor Dzau for a panel discussion on "Affordable Medicines: Access, Innovation, and the Public Interest." The panel also featured former Lockheed Martin CEO
10/20/18 - Sens. Grassley, Warren Issue Statement on FDA Rules on Hearing Aids
Charles E. Grassley, R- Iowa, and Elizabeth Warren, R- Massachusetts, issued the following joint statement applauding the Food and Drug Administration on its action to make more affordable hearing aids available over-the-counter:. "We are pleased that the US Food and Drug Administration will prioritize issuing rules for over-the-counter hearing ai
10/19/18 - FDA Approves Asthma Indication for Dupixent (dupilumab)
TARRYTOWN, N.Y. and PARIS, Oct. 19, 2018/ PRNewswire/. Regeneron Pharmaceuticals, Inc. and Sanofi today announced the U.S. Food and Drug Administration has approved Dupixent as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent as
10/19/18 - FDA approves asthsma indication for Dupixent (dupilumab)
PARIS and TARRYTOWN, N.Y., Oct. 19, 2018/ PRNewswire/ Sanofi. "Dupixent is now approved in the U.S. for two important groups of uncontrolled asthma patients those who are moderate-to-severe with an eosinophilic phenotype or those with oral corticosteroid-dependent asthma," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientifi
10/19/18 - FDA Approves Label Update for Genentech's Rituxan (Rituximab) in Two Rare Forms of Vasculitis
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
10/19/18 - Global Animal Medication Markets, 2016-2024: Market Ripe for Consolidation - Zoetis is the Industry Leader
The "Animal Medication- Global Strategic Business Report" report has been added to ResearchAndMarkets.com' s offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024.
10/19/18 - Janssen Announces New Three-Year TREMFYA (Guselkumab) Data Demonstrates Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis
TREMFYA is the first anti-interleukin -23 monoclonal antibody that was approved by the U.S. Food and Drug Administration and is administered by subcutaneous injection. The findings, presented at the 37th Fall Clinical Dermatology Conference in Las Vegas, Nevada, showed nearly 83 percent of patients receiving TREMFYA in the Phase 3 VOYAGE 1 st
10/19/18 - Sanofi: FDA approves asthma indication for Dupixent (dupilumab)
Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic approved for oral corticosteroid-dependent asthma, regardless of phenotype Only asthma biologic that offers patient self-administration at home Only asthma biologic also approved for adult patients with moderate-to-severe atopic...
10/18/18 - Enzymatica AB: Enzymatica signs agreement for the Japanese market
Press release October 18, 2018 Enzymatica signs agreement for the Japanese market Enzymatica has entered into an agreement with a large Japanese pharmaceutical company regarding registration, marketing, distribution and sales of ColdZyme Mouth Spray for common cold. The agreement provides Enzymatica with access to one of the world's largest heal
10/18/18 - Federal Register Extracts
Agency: " Centers for Medicare& Medicaid Services, HHS." DATES: To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. on December 17, 2018. You may mail written comments to the following address ONLY: Centers for Medicare& Medicaid Services, Department of Health and Human Services, Atten
10/18/18 - Former DEA Agent and Inspiration for Netflix's Narcos Series Announced as Verde Technologies' Newest Advisory Council Member
Verde Technologies, Inc., the maker of the Deterra Drug Deactivation System, a drug deactivation and disposal pouch, announced the addition of Stephen E. Murphy, retired Special Agent in Charge with the Drug Enforcement Administration and inspiration for the hit Netflix series Narcos, to its Deterra Advisory Council. About Murphy and the D
10/18/18 - Former DEA Agent and Inspiration for Netflix's Narcos Series Announced as Verde Techologies' Newest Advisory Council Member
Verde Technologies, Inc., the maker of the Deterra Drug Deactivation System, a drug deactivation and disposal pouch, announced the addition of Stephen E. Murphy, retired Special Agent in Charge with the Drug Enforcement Administration and inspiration for the hit Netflix series Narcos, to its Deterra Advisory Council. About Murphy and the D
10/18/18 - Innovus Pharma Announces Planned Expansion into CBD Oil-Based Products Market
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced that it plans to expand its product line into the hemp-derived CBD oil-based products...
10/18/18 - Medicare and Medicaid Programs; Regulation To Require Drug Pricing Transparency
CFR Part: "42 CFR Part 403". Agency: " Centers for Medicare& Medicaid Services, HHS." DATES: To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. on December 17, 2018.
10/18/18 - Will vitamin D solve the SAD problem?
Q. During a very cold winter, I began to feel more sad than usual, as well as fuzzy, forgetful and achy.This worried me enough to send me to the doctor. All my blood tests were fine except for my vitamin D, which was very low. You are correct that people in Northern states may have difficulty getting enough vitamin D. In fact, the National Health a
10/17/18 - In Vitro Diagnostics Market to Generate US$89862.2 Million Revenue by 2025, Says TMR
According to the report, the global in vitro diagnostics market was valued at US $55000 mn in 2016 and expected to expand with 5.6% CAGR over the forecast period from 2017 to 2025 in order to attain a value of US $89862.2 mn by the end of forecast period. Based on the region, North America dominated the global market for in vitro diagnostics owing
10/17/18 - NEUROMETRIX, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion of our financial condition and results of operations in conjunction with our financial statements and the accompanying notes to those financial statements included elsewhere in this Quarterly Report on Form 10- Q. This discussion contains forward-looking statements that involve risks and uncertainties.
10/17/18 - Pharmaceutical Excipients Market Steadily Growing Pharmaceutical Industry with CAGR of 6.8% Driven by MRFR
Pune, India 10/17/2018 Global Pharmaceutical Excipient Market Overview. With the growing advancement in the pharmaceutical industry, the need to satisfy patient's therapeutic needs is also rising. The Global Pharmaceutical Excipient Market consist of players such as Ashland, Inc., BASF SE, Croda International PLC, Evonik Industries Ag, Fer
10/17/18 - Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements; Draft Guidance for Industry; Availability
Agency: " Food and Drug Administration, HHS." SUMMARY: The Food and Drug Administration is announcing the availability of a draft guidance for industry entitled "Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements. Because your comment will be made public, you are solely responsible fo
10/16/18 - Dupixent (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps
PARIS and TARRYTOWN, N.Y., Oct. 16, 2018/ PRNewswire/ Two pivotal Phase 3 placebo-controlled trials evaluating Dupixent in adults with inadequately-controlled chronic rhinosinusitis with nasal polyps met all primary and secondary endpoints. On the co-primary endpoints for both trials at 24 weeks, patients treated with Dupixent added to a...
10/16/18 - Global Animal Medication Industry
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Company profiles are primarily based on public domain information including company URLs. The report profiles 105 companies including ma
10/16/18 - Singapore Pharmaceutical Market 2012-2017 & 2018-2022
Singapore Pharmaceutical market has registered an increase in the revenue during the period 2012-2017. Many leading biomedical companies such as AbbVie, Pfizer, Ferring Pharmaceuticals and others have selected Singapore as their global manufacturing base. Singapore pharmaceutical market is expected to grow at a single digit CAGR during 2017-2018...
10/16/18 - Singapore Pharmaceutical Market Outlook to 2022 by Prescription & OTC Drugs and Patented & Generic Drugs
Singapore Pharmaceutical market has registered an increase in the revenue during the period 2012-2017. Many leading biomedical companies such as AbbVie, Pfizer, Ferring Pharmaceuticals and others have selected Singapore as their global manufacturing base. Singapore pharmaceutical market is expected to grow at a single digit CAGR during 2017-2018...
10/16/18 - Singapore Pharmaceutical Market Outlook to 2022 by Prescription & OTC Drugs and Patented & Generic Drugs - ResearchAndMarkets.com
The " Singapore Pharmaceutical Market Outlook to 2022- by Prescription& OTC Drugs and by Patented& Generic Drugs" report has been added to ResearchAndMarkets.com' s offering. Singapore Pharmaceutical market has registered an increase in the revenue during the period 2012-2017. Many leading biomedical companies such as AbbVie, Pfizer, Ferring...
10/16/18 - TRxADE GROUP, INC. Announces Acquisition of Independent Specialty Pharmacy
TAMPA, FL/ ACCESSWIRE/ October 16, 2018/ Trxade Group, Inc., a web-based pharmaceutical sourcing and purchasing platform with 9,300 registered independent pharmacy customers that procure over $100 M in drug and product purchases annually, today announced the acquisition of Retail Specialty Pharmacy, an Independent Pharmacy. "Retail Pharmacy Acquis
Articles(s): 1 - 25 of 28     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415